Cite

HARVARD Citation

    Goldberg, S. et al. (2013). Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non‐Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors. Oncologist. pp. 1214-1220. [Online]. 
  
Back to record